CIRSE Standards of Practice on Thermal Ablation of Bone Tumours.
Bone tumours
Cryoablation
HIFU
Interventional pain management
Laser ablation
Microwave ablation
Radiofrequency ablation
Journal
Cardiovascular and interventional radiology
ISSN: 1432-086X
Titre abrégé: Cardiovasc Intervent Radiol
Pays: United States
ID NLM: 8003538
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
received:
14
09
2021
accepted:
28
01
2022
pubmed:
30
3
2022
medline:
22
4
2022
entrez:
29
3
2022
Statut:
ppublish
Résumé
Percutaneous thermal ablation is an effective, minimally invasive means of treating a variety of focal benign and malignant osseous lesions. To determine the role of ablation in individual cases, multidisciplinary team (MDT) discussion is required to assess the suitability and feasibility of a thermal ablative approach, to select the most appropriate technique and to set the goals of treatment i.e. curative or palliative. This document will presume the indication for treatment is clear and approved by the MDT and will define the standards required for the performance of each modality. CIRSE Standards of Practice documents are not intended to impose a standard of clinical patient care, but recommend a reasonable approach to, and best practices for, the performance of thermal ablation of bone tumours. The writing group was established by the CIRSE Standards of Practice Committee and consisted of five clinicians with internationally recognised expertise in thermal ablation of bone tumours. The writing group reviewed the existing literature on thermal ablation of bone tumours, performing a pragmatic evidence search using PubMed to search for publications in English and relating to human subjects from 2009 to 2019. Selected studies published in 2020 and 2021 during the course of writing these standards were subsequently included. The final recommendations were formulated through consensus. Recommendations were produced for the performance of thermal ablation of bone tumours taking into account the biologic behaviour of the tumour and the therapeutic intent of the procedure. Recommendations are provided based on lesion characteristics and thermal modality, for the use of tissue monitoring and protection, and for the appropriately timed application of adjunctive procedures such as osseus consolidation and transarterial embolisation. Percutaneous thermal ablation has an established role in the successful management of bone lesions, with both curative and palliative intent. This Standards of Practice document provides up-to-date recommendations for the safe performance of thermal ablation of bone tumours.
Sections du résumé
BACKGROUND
BACKGROUND
Percutaneous thermal ablation is an effective, minimally invasive means of treating a variety of focal benign and malignant osseous lesions. To determine the role of ablation in individual cases, multidisciplinary team (MDT) discussion is required to assess the suitability and feasibility of a thermal ablative approach, to select the most appropriate technique and to set the goals of treatment i.e. curative or palliative.
PURPOSE
OBJECTIVE
This document will presume the indication for treatment is clear and approved by the MDT and will define the standards required for the performance of each modality. CIRSE Standards of Practice documents are not intended to impose a standard of clinical patient care, but recommend a reasonable approach to, and best practices for, the performance of thermal ablation of bone tumours.
METHODS
METHODS
The writing group was established by the CIRSE Standards of Practice Committee and consisted of five clinicians with internationally recognised expertise in thermal ablation of bone tumours. The writing group reviewed the existing literature on thermal ablation of bone tumours, performing a pragmatic evidence search using PubMed to search for publications in English and relating to human subjects from 2009 to 2019. Selected studies published in 2020 and 2021 during the course of writing these standards were subsequently included. The final recommendations were formulated through consensus.
RESULTS
RESULTS
Recommendations were produced for the performance of thermal ablation of bone tumours taking into account the biologic behaviour of the tumour and the therapeutic intent of the procedure. Recommendations are provided based on lesion characteristics and thermal modality, for the use of tissue monitoring and protection, and for the appropriately timed application of adjunctive procedures such as osseus consolidation and transarterial embolisation.
RESULTS
RESULTS
Percutaneous thermal ablation has an established role in the successful management of bone lesions, with both curative and palliative intent. This Standards of Practice document provides up-to-date recommendations for the safe performance of thermal ablation of bone tumours.
Identifiants
pubmed: 35348870
doi: 10.1007/s00270-022-03126-x
pii: 10.1007/s00270-022-03126-x
pmc: PMC9018647
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
591-605Informations de copyright
© 2022. The Author(s).
Références
Radiology. 2003 Oct;229(1):171-5
pubmed: 12944597
Skeletal Radiol. 2002 Oct;31(10):559-69
pubmed: 12324824
Semin Intervent Radiol. 2017 Dec;34(4):328-336
pubmed: 29249856
PLoS One. 2015 Jun 23;10(6):e0129021
pubmed: 26103516
AJNR Am J Neuroradiol. 2018 Jul;39(7):1376-1383
pubmed: 29794238
Int J Hyperthermia. 2017 Sep;33(6):670-674
pubmed: 28540776
Eur Radiol. 2010 Oct;20(10):2439-46
pubmed: 20467872
Eur Radiol. 2019 Oct;29(10):5655-5663
pubmed: 30877460
Eur Radiol. 2018 Jun;28(6):2336-2344
pubmed: 29294152
Eur Radiol. 2011 Sep;21(9):2004-10
pubmed: 21533865
Radiology. 2016 Mar;278(3):936-43
pubmed: 26383230
Cardiovasc Intervent Radiol. 2021 Sep;44(9):1323-1353
pubmed: 34231007
J Neurosurg Spine. 2012 Apr;16(4):379-86
pubmed: 22225488
Diagn Interv Imaging. 2021 Jan;102(1):27-34
pubmed: 32482583
Int J Hyperthermia. 2018;35(1):471-479
pubmed: 30208747
Skeletal Radiol. 2015 Feb;44(2):285-9
pubmed: 25091121
J Neurointerv Surg. 2018 Feb;10(2):176-182
pubmed: 28385727
Technol Cancer Res Treat. 2007 Dec;6(6):635-40
pubmed: 17994794
Cardiovasc Intervent Radiol. 2021 Jan;44(1):118-126
pubmed: 33089359
Pathol Oncol Res. 2014 Oct;20(4):885-91
pubmed: 24781761
Cryobiology. 1985 Apr;22(2):175-82
pubmed: 3979086
J Vasc Interv Radiol. 2015 Jun;26(6):905-9
pubmed: 26003456
AJR Am J Roentgenol. 2019 Nov;213(5):1157-1162
pubmed: 31310180
Eur J Radiol. 2018 Mar;100:116-123
pubmed: 29496068
Cardiovasc Intervent Radiol. 2016 Jan;39(1):74-80
pubmed: 26071108
Clin Radiol. 2020 Sep;75(9):713.e11-713.e16
pubmed: 32586642
J Vasc Interv Radiol. 2020 Nov;31(11):1745-1752
pubmed: 33129427
Technol Cancer Res Treat. 2017 Oct;16(5):570-576
pubmed: 27480322
Cryobiology. 1984 Apr;21(2):157-69
pubmed: 6713945
AJNR Am J Neuroradiol. 2016 Jan;37(1):189-95
pubmed: 26427837
PET Clin. 2018 Oct;13(4):579-585
pubmed: 30219189
World J Surg. 1999 Oct;23(10):1019-26
pubmed: 10512941
Neuroradiology. 2019 Aug;61(8):935-942
pubmed: 31161261
Skeletal Radiol. 2011 Jan;40(1):25-32
pubmed: 20686765
Skeletal Radiol. 2019 Aug;48(8):1161-1169
pubmed: 30627778
Cryobiology. 2020 Feb 1;92:203-207
pubmed: 31958427
Clin Oncol (R Coll Radiol). 2006 Dec;18(10):747-60
pubmed: 17168210
Cardiovasc Intervent Radiol. 2017 Feb;40(2):166-176
pubmed: 27826789
Eur J Radiol. 2019 Oct;119:108650
pubmed: 31525680
Cancer. 2013 Mar 1;119(5):1033-41
pubmed: 23065947
Semin Musculoskelet Radiol. 2013 Apr;17(2):189-202
pubmed: 23673550
Med Oncol. 2016 Dec;33(12):140
pubmed: 27837451
Eur Radiol. 2020 Nov;30(11):5952-5963
pubmed: 32518986
Nature. 1983 Dec 15-21;306(5944):686-8
pubmed: 6656869
Cardiovasc Intervent Radiol. 2018 May;41(5):726-733
pubmed: 29204695
Cryobiology. 2021 Jun;100:1-11
pubmed: 33639110
Cardiovasc Intervent Radiol. 2012 Apr;35(2):244-6
pubmed: 22011783
Radiology. 2019 May;291(2):521-528
pubmed: 30806603
J Natl Cancer Inst. 2014 Apr 23;106(5):
pubmed: 24760791
Cardiovasc Intervent Radiol. 2020 Sep;43(9):1371-1377
pubmed: 32642988
Radiology. 2003 Jun;227(3):691-700
pubmed: 12773675
Radiology. 1998 Nov;209(2):381-5
pubmed: 9807562
Oncologist. 2015 Oct;20(10):1205-15
pubmed: 26354526
AJNR Am J Neuroradiol. 2017 May;38(5):852-861
pubmed: 28183835
J Vasc Interv Radiol. 2013 Feb;24(2):229-33
pubmed: 23200605
Eur Radiol. 2014 Aug;24(8):1971-80
pubmed: 24859596
Ann Surg Oncol. 2003 Apr;10(3):275-83
pubmed: 12679313
Int J Hyperthermia. 2018 Dec;34(8):1272-1281
pubmed: 29308694
Oncology. 1966;20:Suppl:18-29
pubmed: 5926982
J Vasc Interv Radiol. 2020 Nov;31(11):1753-1762
pubmed: 33012648
Semin Musculoskelet Radiol. 2020 Jun;24(3):310-322
pubmed: 32987428
J Pain. 2008 Sep;9(9):771-83
pubmed: 18562251
Eur J Surg Oncol. 2007 Jun;33(5):590-6
pubmed: 17321714
Cryobiology. 2009 Dec;59(3):229-43
pubmed: 19833119
J Neurosurg Spine. 2020 Aug 14;:1-7
pubmed: 32796141
AJR Am J Roentgenol. 2020 Aug;215(2):502-510
pubmed: 32452697
Radiographics. 2013 Oct;33(6):1555-68
pubmed: 24108551
J Vasc Interv Radiol. 2013 Feb;24(2):207-13
pubmed: 23265724
J Pediatr Orthop. 2008 Mar;28(2):265-70
pubmed: 18388727
Skeletal Radiol. 2014 Nov;43(11):1551-9
pubmed: 24972918
Invest Radiol. 2013 Jun;48(6):351-8
pubmed: 23571832
J Ther Ultrasound. 2016 May 20;4:16
pubmed: 27213043
J Vasc Interv Radiol. 2020 Jun;31(6):903-911
pubmed: 32340861
Pediatr Radiol. 2019 Aug;49(9):1209-1216
pubmed: 31129699
Radiographics. 2010 May;30(3):737-49
pubmed: 20462991
Cardiovasc Intervent Radiol. 2019 Mar;42(3):344-357
pubmed: 30310986
J Vasc Interv Radiol. 2016 Dec;27(12):1788-1796
pubmed: 27745968
Radiol Clin North Am. 1998 May;36(3):547-57
pubmed: 9597072
Int J Hyperthermia. 2019 Oct;36(2):3-12
pubmed: 31537154
Eur Radiol. 2021 May;31(5):3530-3541
pubmed: 33155107
Skeletal Radiol. 2017 Mar;46(3):315-323
pubmed: 28028574
Acta Neurochir Suppl (Wien). 1987;39:177-80
pubmed: 2823542
Oncol Lett. 2017 Jan;13(1):155-158
pubmed: 28123536
Cardiovasc Intervent Radiol. 2018 Aug;41(8):1223-1232
pubmed: 29541840
Radiology. 2007 Jan;242(1):293-301
pubmed: 17090708
Cardiovasc Intervent Radiol. 2014 Jun;37(3):730-6
pubmed: 24091753
Radiographics. 2018 Mar-Apr;38(2):603-623
pubmed: 29394144
Radiology. 2020 Jul;296(1):227-235
pubmed: 32343213